Winthrop Advisory Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$987K Sell
4,538
-183
-4% -$40.6K 0.08% 75
2025
Q4
$1.07M Buy
4,721
+255
+6% +$58.1K 0.09% 69
2025
Q3
$1.03M Sell
4,466
-89
-2% -$18.1K 0.09% 68
2025
Q2
$845K Buy
4,555
+1,450
+47% +$269K 0.08% 74
2025
Q1
$651K Sell
3,105
-1,389
-31% -$270K 0.08% 74
2024
Q4
$799K Buy
4,494
+1,149
+34% +$211K 0.1% 69
2024
Q3
$661K Sell
3,345
-67
-2% -$12.5K 0.08% 73
2024
Q2
$585K Sell
3,412
-170
-5% -$28.2K 0.08% 73
2024
Q1
$652K Buy
3,582
+78
+2% +$13.4K 0.09% 67
2023
Q4
$543K Sell
3,504
-58
-2% -$8.46K 0.08% 72
2023
Q3
$531K Buy
3,562
+124
+4% +$18.2K 0.09% 67
2023
Q2
$463K Buy
3,438
+26
+0.8% +$3.81K 0.07% 78
2023
Q1
$544K Buy
3,412
+9
+0.3% +$1.38K 0.1% 68
2022
Q4
$550K Sell
3,403
-1,041
-23% -$160K 0.1% 67
2022
Q3
$596K Buy
4,444
+1
+0% +$143 0.13% 56
2022
Q2
$680K Buy
4,443
+1
+0% +$153 0.16% 50
2022
Q1
$720K Buy
4,442
+502
+13% +$72.9K 0.15% 53
2021
Q4
$533K Buy
3,940
+11
+0.3% +$1.3K 0.11% 65
2021
Q3
$424K Buy
3,929
+1,804
+85% +$206K 0.09% 65
2021
Q2
$239K Sell
2,125
-18
-0.8% -$2.03K 0.05% 113
2021
Q1
$232K Buy
2,143
+16
+0.8% +$1.71K 0.06% 116
2020
Q4
$228K Buy
+2,127
New +$204K 0.06% 112

Other funds holding ABBV